Burke & Herbert Bank & Trust Co. Has $836,000 Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Burke & Herbert Bank & Trust Co. grew its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 35.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,800 shares of the company’s stock after acquiring an additional 2,315 shares during the period. Burke & Herbert Bank & Trust Co.’s holdings in VanEck Pharmaceutical ETF were worth $836,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of PPH. Thrivent Financial for Lutherans acquired a new position in VanEck Pharmaceutical ETF during the second quarter worth approximately $16,088,000. Northwestern Mutual Wealth Management Co. boosted its stake in shares of VanEck Pharmaceutical ETF by 1.7% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 160,039 shares of the company’s stock worth $14,641,000 after acquiring an additional 2,694 shares during the period. Financial Partners Group Inc acquired a new position in shares of VanEck Pharmaceutical ETF during the 2nd quarter worth approximately $8,701,000. Adamsbrown Wealth Consultants LLC bought a new stake in VanEck Pharmaceutical ETF in the 3rd quarter valued at $7,030,000. Finally, J.Safra Asset Management Corp lifted its holdings in VanEck Pharmaceutical ETF by 5.9% during the 2nd quarter. J.Safra Asset Management Corp now owns 73,609 shares of the company’s stock valued at $6,734,000 after purchasing an additional 4,084 shares during the last quarter.

VanEck Pharmaceutical ETF Price Performance

PPH stock traded up $0.13 during midday trading on Friday, reaching $92.60. 9,441 shares of the company were exchanged, compared to its average volume of 138,196. VanEck Pharmaceutical ETF has a one year low of $74.05 and a one year high of $99.51. The firm has a market capitalization of $679.68 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The business has a 50-day moving average price of $96.06 and a two-hundred day moving average price of $92.51.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.